SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Biosimilars Market by Product & Application - Global Forecast to 2018

[December 02, 2013]

Research and Markets: Biosimilars Market by Product & Application - Global Forecast to 2018

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/73bwmf/biosimilars) has announced the addition of the "Biosimilars Market by Product & Application - Global Forecast to 2018" report to their offering.

The biosimilar product market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; while the recombinant glycosylated proteins market is further broken down into erythropoietin, monoclonal antibodies, and follitropin. Calcitonin and glucagon are considered in the recombinant peptides market.

The recombinant glycosylated proteins segment is expected to witness the highest growth due to the increased demand for monoclonal antibodies in the treatment for cancer (oncology), autoimmune disorders, blood disorders, and infectious diseases. Oncology will be the fastest-growing segment and currently accounts for a 25% market share in the global market in 2013. Following monoclonal antibodies, biosimilars of insulin will be the fastest-growing products and are estimated to grow at a CAGR of 35.6% from 2013 to 2018. The growth is attributed to the rise in incidences of diabetes; ongoing patent expirations of biologic drugs such as Lantus, Humalog, and Novorapid; and the cost effectiveness of the biosimilars of insulin.

The global market is highly consolidated with the top three players, naely, Sandoz (Germany), Hospira (U.S.), and Teva (Israel) accounting for approximately 90% of the market share. Other notable players in the market include Dr. Reddy's Laboratories (India), Biocon Ltd. (India), Mylan (U.S.), Biopartners (Switzerland), Amgen (U.S.), and IntasBiopharmaceutical Ltd. (India).


The competitive landscape covers the growth strategies adopted by the industry players in the last three years. The company profiles comprise of the basic views on the key players in the biosimilars market and the product portfolios, developments, and strategies adopted to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

This study covers the revenue market of recombinant glycosylated proteins, recombinant non-glycosylated proteins, and recombinant peptides, the three major drug classes of the market. The sales revenue of each biosimilar drug was considered to estimate the global market. The market revenue for each therapeutic area was calculated based on the type of drugs used to treat a particular disease. The market share of the key players involved in manufacturing and commercializing biosimilar products was considered to estimate the market.

Key Topics Covered:

Introduction

Executive Summary

Premium Insights

Market Overview

Industry Analysis

Global Biosimilars Market, By Product

Global Biosimilars Market, By Application

Global Biosimilars Service Market

Geographic Analysis

Competitive Landscape

Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List of Tables (80 Tables)

List of Figures (80 Figures)

Companies Mentioned

- Actavis, Inc

- Amgen, Inc

- Biocon Ltd

- Celltrion, Inc

- Cipla Ltd

- Dr Reddy's Laboratories Ltd

- Emcure Pharmaceuticals Ltd

- Hospira, Inc

- Lg Life Sciences Ltd

- Merck Kgaa

- Mylan, Inc

- Ranbaxy Laboratories Ltd

- Roche Holding Ltd

- Sandoz International GMBH (Division Of Novartis International Ag)

- Stada Arzneimittel Ag

- Synthon

- Teva Pharmaceutical Industries Ltd

- Wockhardt Ltd

For more information visit http://www.researchandmarkets.com/research/73bwmf/biosimilars

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.